ORIC Pharmaceuticals Inc (FRA:4TZ)
€ 9.13 -0.26 (-2.77%) Market Cap: 986.27 Mil Enterprise Value: 741.60 Mil PE Ratio: 0 PB Ratio: 2.64 GF Score: 32/100

Oric Pharmaceuticals Inc Enozertinib (ORIC-114) Program Update Call Transcript

Dec 6, 2025 / 01:00 AM GMT


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ORIC.OQ - Oric Pharmaceuticals Inc
Oric Pharmaceuticals Inc Enozertinib (ORIC-114) Program Update Call
Dec 07, 2025 / 01:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the Aic Enozertiib program update conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising that your hand has been raised. To withdraw your question, please press 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker, Dominic Piccitelli, Chief Financial Officer. Please go ahead.

---------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot